We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
1701
Vanda Pharmaceuticals
VNDA
$307M
$278K ﹤0.01%
24,336
– –
SRCE icon
1702
1st Source
SRCE
$2.15B
$278K ﹤0.01%
7,814
+2,242
+40% +$74.2K
UMH
1703
UMH Properties
UMH
$1.41B
$278K ﹤0.01%
21,470
+6,645
+45% +$80.3K
VVX icon
1704
V2X
VVX
$2.53B
$277K ﹤0.01%
5,647
– –
ARCB icon
1705
ArcBest
ARCB
$3.26B
$277K ﹤0.01%
10,451
– –
PRVB
1706
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$277K ﹤0.01%
+19,627
New +$248K
ATEX icon
1707
Anterix
ATEX
$1.8B
$277K ﹤0.01%
6,099
+1,618
+36% +$82.7K
HBNC icon
1708
Horizon Bancorp
HBNC
$1.06B
$276K ﹤0.01%
25,810
+8,254
+47% +$84.2K
PAE
1709
DELISTED
PAE Incorporated Class A Common Stock
PAE
$276K ﹤0.01%
+28,855
New +$257K
SHYF
1710
DELISTED
The Shyft Group
SHYF
$275K ﹤0.01%
16,327
– –
MATW icon
1711
Matthews International
MATW
$728M
$274K ﹤0.01%
14,349
– –
TFIN icon
1712
Triumph Financial Inc
TFIN
$1.88B
$273K ﹤0.01%
11,267
– –
AGM icon
1713
Federal Agricultural Mortgage
AGM
$2.52B
$273K ﹤0.01%
4,263
– –
NXGN
1714
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$272K ﹤0.01%
24,814
– –
GIII icon
1715
G-III Apparel Group
GIII
$1.43B
$272K ﹤0.01%
20,478
– –
CVI icon
1716
CVR Energy
CVI
$3.57B
$272K ﹤0.01%
13,526
– –
BOOT icon
1717
Boot Barn
BOOT
$4.99B
$272K ﹤0.01%
12,612
– –
VREX icon
1718
Varex Imaging
VREX
$781M
$271K ﹤0.01%
17,885
– –
TRST
1719
Trustco Bank Corp NY
TRST
$974M
$271K ﹤0.01%
8,550
– –
EBSB
1720
DELISTED
Meridian Bancorp, Inc.
EBSB
$270K ﹤0.01%
23,292
– –
KNL
1721
DELISTED
Knoll, Inc.
KNL
$270K ﹤0.01%
22,127
– –
ICHR icon
1722
Ichor Holdings
ICHR
$2.72B
$270K ﹤0.01%
10,143
– –
UFCS icon
1723
United Fire Group
UFCS
$1.37B
$268K ﹤0.01%
9,677
– –
CYBR
1724
DELISTED
CyberArk
CYBR
$268K ﹤0.01%
2,700
– –
QNST icon
1725
QuinStreet
QNST
$1.2B
$268K ﹤0.01%
25,601
+7,663
+43% +$73.9K
67 68
69
70 71

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.